I.E. Smith

Change in oestrogen receptor expression and function in tamoxifen-resistant breast cancer

Stephen Johnston, Gloria Saccani‐Jotti, I.E. Smith et al. · Endocrine Related Cancer · 1995 · 27 citations

Oestrogen Receptor Expression, Breast Oncology, Tamoxifen-resistant Breast Cancer +11

Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer—How low can you go?

Yoon Sim Yap, Anne Kendall, G. Walsh et al. · The Breast · 2007 · 23 citations

Breast Oncology, Oncology, Cancer Management +8

Moderate dose capecitabine in older patients with metastatic breast cancer: A standard option for first line treatment?

Aekaterini A. Kotsori, Jill Noble, S. Ashley et al. · The Breast · 2010 · 19 citations · Full text

Standard Option, Metastatic Breast Cancer, Breast Oncology +13

101. Change in expression of epidermal growth factor receptor and c-erb-B2 during the development of tamoxifen resistance in human breast cancer

Jacqueline C. Newby, Stephen Johnston, I.E. Smith et al. · The Breast · 1995 · 10 citations · Full text

Breast Oncology, Tamoxifen Resistance, Medicine +9